EBV-CTL: Additional Phase II data

Data from 14 patients with metastatic EBV-positive nasopharyngeal carcinoma in the open-label, U.S. Phase II 11-130 trial showed

Read the full 183 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE